Results by group45

Each measurement the trial posted, group by group, in the words and numbers it posted.

41 to 45 of 45

Outcome	Group	Category	Value	Spread	Units
Change From Baseline in Insulin Resistance (HOMA2-IR)	Placebo	week 12	0.76	80% Confidence Interval 0.50 to 1.02	Insulin Resistance (IR) Score
Change From Baseline in Insulin Resistance (HOMA2-IR)	BYM338 10 mg/kg	week 36	-0.09	80% Confidence Interval -0.44 to 0.25	Insulin Resistance (IR) Score
Change From Baseline in Insulin Resistance (HOMA2-IR)	Placebo	week 36	0.57	80% Confidence Interval 0.24 to 0.90	Insulin Resistance (IR) Score
Immunogenicity Assessed by the Number of Participants Developing Anti-BYM338 Antibodies During the Trial	BYM338 10 mg/kg	Confirmed with positive immunogenicity	2		Participants
Immunogenicity Assessed by the Number of Participants Developing Anti-BYM338 Antibodies During the Trial	Placebo	Confirmed with positive immunogenicity	4		Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03005288/results?page=3